Israeli-founded medical imaging company Rhythmia has been sold to American medical corporation Boston Scientific. The Israeli company, which develops next generation mapping and navigation solutions used in cardiac catheter ablations and other electrophysiology procedures, was sold for $265 million.
Related posts
Satellites To Seek Out Underground Reserves Of Lithium
August 16, 2022
Israel To Launch Renewable Energy Projects In 7 Arab Countries
August 16, 2022
Israeli Secure Enterprise Browser Provider Raises $100M
August 15, 2022
Wiz Becomes World’s Fastest-Growing Software Company
August 15, 2022
Facebook comments